ANTAGONISM OF CERULETIDE, A CHOLECYSTOKININ ANALOG, TO THE NEUROCHEMICAL EFFECTS OF THE NONCOMPETITIVE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONISTS, PHENCYCLIDINE AND MK-801, ON REGIONAL DOPAMINERGIC-NEURONS IN THE RAT-BRAIN

被引:6
作者
KUROKI, T [1 ]
TATEBAYASHI, Y [1 ]
IDE, K [1 ]
YONEZAWA, Y [1 ]
TSUTSUMI, T [1 ]
MATSUMOTO, T [1 ]
HIRANO, M [1 ]
UCHIMURA, H [1 ]
机构
[1] HIZEN NATL MENTAL HOSP,CTR EMOT & BEHAV DISORDERS,NEUROCHEM LAB,KANZAKI,SAGA 84201,JAPAN
关键词
D O I
10.1016/0143-4179(92)90041-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present study, we investigated the effects of ceruletide (CL), a cholecystokinin analog, on the neurochemical response to non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine (PCP) and MK-801, of the dopaminergic neuron systems in the discrete regions of the rat brain. Systemically administered PCP (7.5 mg/kg, i.p.) or MK-801 (1.0 mg/kg, i.p.) produced significant increases in the tissue contents of dopamine metabolite, homovanillic acid (HVA), in the prefrontal cortex, the nucleus accumbens and the olfactory tubercle but not in the nucleus caudatus putamen after 60 min. The effects of NMDA receptor antagonists in the nucleus accumbens and the prefrontal cortex were partially antagonized by pretreatment with CL (80 and 400-mu-g/kg, i.p., at 60 min prior to the drugs). While CL alone decreased the dopaminergic metabolism only in the nigrostriatal pathways in naive rats, the present results indicated that CL also attenuates the activities of the meso-limbic and meso-cortical dopaminergic neuron systems when these are enhanced by either PCP or MK-801.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 27 条
[1]  
AKIYOSHI T, 1990, NEUROPEPTIDE BASIC C, P269
[2]   INHIBITION OF POTASSIUM-EVOKED RELEASE OF CHOLECYSTOKININ FROM RAT CAUDATE-PUTAMEN, CEREBRAL-CORTEX AND HIPPOCAMPUS INCUBATED INVITRO BY PHENCYCLIDINE AND RELATED-COMPOUNDS [J].
ALLARD, LR ;
BROG, JS ;
VIERECK, JC ;
CONTRERAS, PC ;
JACOBSON, AE ;
RICE, KC ;
BEINFELD, MC .
BRAIN RESEARCH, 1990, 522 (02) :224-226
[3]   CHOLECYSTOKININ ATTENUATES BASAL AND DRUG-INDUCED INCREASES OF LIMBIC AND STRIATAL DOPAMINE RELEASE [J].
ALTAR, CA ;
BOYAR, WC ;
OEI, E ;
WOOD, PL .
BRAIN RESEARCH, 1988, 460 (01) :76-82
[4]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[5]   PHENCYCLIDINE - PHYSIOLOGICAL ACTIONS, INTERACTIONS WITH EXCITATORY AMINO-ACIDS AND ENDOGENOUS LIGANDS [J].
CONTRERAS, PC ;
MONAHAN, JB ;
LANTHORN, TH ;
PULLAN, LM ;
DIMAGGIO, DA ;
HANDELMANN, GE ;
GRAY, NM ;
ODONOHUE, TL .
MOLECULAR NEUROBIOLOGY, 1987, 1 (03) :191-211
[6]   MESOLIMBIC AND MESOCORTICAL DOPAMINE ACTIVATION INDUCED BY PHENCYCLIDINE - CONTRASTING PATTERN TO STRIATAL RESPONSE [J].
DEUTCH, AY ;
TAM, SY ;
FREEMAN, AS ;
BOWERS, MB ;
ROTH, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 134 (03) :257-264
[7]   ACTIVATION OF NMDA RECEPTORS INDUCES DEPHOSPHORYLATION OF DARPP-32 IN RAT STRIATAL SLICES [J].
HALPAIN, S ;
GIRAULT, JA ;
GREENGARD, P .
NATURE, 1990, 343 (6256) :369-372
[8]  
HIRAMATSU M, 1989, EUR J PHARMACOL, V166, P359
[9]  
HIRANO M, 1990, 17TH C COLL INT NEUR, V2, P369
[10]   EVIDENCE FOR COEXISTENCE OF DOPAMINE AND CCK IN MESO-LIMBIC NEURONS [J].
HOKFELT, T ;
REHFELD, JF ;
SKIRBOLL, L ;
IVEMARK, B ;
GOLDSTEIN, M ;
MARKEY, K .
NATURE, 1980, 285 (5765) :476-478